{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-039710","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.447030+00:00","generated_at":"2026-05-23T04:41:57.394745+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"United Therapeutics enters $2.5B revolving credit facility, repays $200M of existing debt","bullets":["New $2.5B unsecured revolving credit facility, with option to increase by up to $750M.","Borrowed $200M at closing to repay outstanding indebtedness under 2022 credit agreement.","Five-year maturity, with two potential one-year extensions at lenders' option.","Financial covenants: consolidated total leverage ≤3.50x and interest coverage ≥3.00x."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-039710","json":"https://secwatch.observer/filing/0001104659-25-039710.json","markdown":"https://secwatch.observer/filing/0001104659-25-039710.md","text":"https://secwatch.observer/filing/0001104659-25-039710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/0001104659-25-039710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465925039710/tm2512890d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:41:57.394745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}